Filtry
Proliferation structure of the embryonic kidney as a target of action of adverse enviromental factors (GA304/04/0972)
acceleration (in case of unilateral kidney aplasia). As we deal with an organ that belongs an experimentally induced unilateral kidney aplasia. We will focus on both the tubular......
EA - Morfologické obory a cytologie
- 2004 - 2006 •
- 1 489 tis. Kč •
- 1 489 tis. Kč •
- GA ČR
Řešení projektu: 1. 1. 2004 - 1. 1. 2006
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Grantová agentura České republiky
Primary ciliary aplasia (OK 266)
Isolation of gamma-tubulins from RBL cells and from brain tissue on preparative columns with bound TU-31 antibody. Electrophoretic analysis of isolated gamma-tubulins by 2D-electrophoresis and by high-resolution isoelectric focusing. Biochemical anal...
EI - Biotechnologie a bionika
- 1997 - 1999 •
- 3 780 tis. Kč •
- 2 080 tis. Kč •
- MŠMT
Řešení projektu: 1. 1. 1997 - 1. 1. 1999
Uznané náklady
Podpora ze státního rozpočtu (55%)
Poskytovatel: Ministerstvo školství, mládeže a tělovýchovy
Diamond-Blackfan anaemia molecular-genetic analysis of ethiopathogenetic factors, analysis of their influence on prognosis and treatment. (NT11059)
Diamond-Blackfan anaemia (DBA) is a rare inherited erythroid aplasia. The etiology was only partly elucidated in 1999 with the discovery of mutated ribosomal protein (RP) S19. DBA is the first known hematological disease caused by ribosomal ...
FG - Pediatrie
- 2010 - 2013 •
- 6 244 tis. Kč •
- 6 244 tis. Kč •
- MZ
Řešení projektu: 1. 9. 2010 - 31. 12. 2013
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
Diamond-Blackfan anemia as a congenital ribosomopathy molecular, cellular and clinical aspects (NV16-32105A)
Diamond-Blackfan anemia (DBA) is a rare inherited erythroid aplasia diagnosed in early infancy in 90% of cases and the first human disease caused by mutations in ribosomal proteins (RP). Despite intensive research, there are still many unres...
FG - Pediatrie
- 2016 - 2020 •
- 12 390 tis. Kč •
- 12 259 tis. Kč •
- MZ
Řešení projektu: 1. 4. 2016 - 31. 12. 2020
Uznané náklady
Podpora ze státního rozpočtu (99%)
Poskytovatel: Ministerstvo zdravotnictví
- 1 - 4 z 4